The
Effect of LDL Apheresis on Platelet and Leukocyte Activation,
Leukocyte-Platelet Aggregation, Kaneka American/Parke Davis
Pharmaceuticals, Principal Investigator (Collaboration with
Andrew P. Selwyn, M.D., Brigham and Women's Hospital), $23,750
Direct Costs
Detection
of Platelet Surface CD40L and Soluble CD40L: Effects of
GPIIb-IIIa Antagonists. Principal Investigator, Centocor,
Inc. $78,166 Direct Costs
Randomized
Evaluation in PCI Linking Angiomax to Reduced Clinical Events
(REPLACE 2). Principal Investigator. The Medicines Company.
$64,000 Direct Costs
Correlation
Of In Vitro And In Vivo Determination Of Aspirin Resistance.
Principal Investigator, Dade Behring, $225,797 Direct Costs
Effects
of the Medtronic Distal Protection Device on Platelet Activation
(Phase 1 & 2) Principal Investigator, Medtronic AVE, $62,
000 Direct Costs